Status:
UNKNOWN
Hypnosis in Treating Hot Flashes in Breast Cancer Survivors
Lead Sponsor:
Scott and White Hospital & Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Cancer Survivor
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
RATIONALE: Hypnosis may be effective in decreasing hot flashes in breast cancer survivors. PURPOSE: This randomized clinical trial is studying how well hypnosis works in treating hot flashes in breas...
Detailed Description
OBJECTIVES: * Determine the efficacy of hypnosis in controlling hot flashes in women who are breast cancer survivors. * Determine the extent to which hypnotizability is related to the success of the ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- History of primary breast cancer
- No evidence of detectable disease
- At least 14 hot flashes per week for ≥ 1 month by self-reporting
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Female
- Life expectancy \> 6 months
- Menopausal status not specified
- Outpatient status
- No medical or psychiatric condition that would preclude study participation
- PRIOR CONCURRENT THERAPY:
- Concurrent antihormonal agents for breast cancer (e.g., tamoxifen or raloxifene) allowed provided the patient has been on them for ≥ 1 month
- No other concurrent hormonal therapy
- No other putative therapies for hot flashes ≥ 1 month prior to study entry
- Concurrent vitamin E allowed
- No other concurrent treatment for hot flashes
- No concurrent cytotoxic chemotherapy
- Not concurrently using hypnosis for any reason
Exclusion
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00094133
Start Date
April 1 2006
Last Update
September 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scott and White Cancer Institute
Temple, Texas, United States, 76508